Skip to main content

Follicular Lymphoma

Follicular Lymphoma

News
More
Odronextamab Appears Safe, Effective in Relapsed/Refractory Follicular Lymphoma
Cancer Therapy Advisor
3w ago
medicine
Addition of Atezolizumab to Obinutuzumab-Bendamustine Does Not Improve PFS in Previously Untreated Follicular Lymphoma
Hematology Advisor
2m ago
treatment
Novel, Minimally Invasive Test Detects Higher Frequency of EZH2 Mutations in Follicular Lymphoma
Oncology Learning Network
2m ago
hospital patient
Transformation of FL Into DLBCL With a PMBL Gene Expression Signature
Blood Advances
3m ago
Genomic and Microenvironmental Landscape of Stage I Follicular Lymphoma, Compared With Stage III/IV
Blood Advances
3m ago
Closeup of doctor wearing surgical gloves working with vials of solution.
Follicular Lymphoma Microenvironment Characteristics Associated with Tumor Cell Mutations and MHC Class II Expression
Blood Cancer Discovery
4m ago
Male and female scientist wearing lab coat and PPE looking at a file.
Cytopenias After Axicabtagene Ciloleucel Therapy for Large B-cell Lymphoma
Hematology Advisor
4m ago
IV
Comparative Effectiveness of ZUMA-5 (axi-cel) vs SCHOLAR-5 External Control in Relapsed/Refractory Follicular Lymphoma
Blood
5m ago
Efficacy Comparison of Tisagenlecleucel vs Usual Care in Patients With Relapsed or Refractory Follicular Lymphoma
Blood Advances
5m ago
light blood cell
TV
More
How IRF4 Shapes the Tumor Microenvironment of Follicular Lymphoma
Aggrego Oncology
3w ago
Analysis of Online Treatment Decision Tool Reveals Variation in FL Management Between Experts and Oncology HCPs
Journal of Clinical Pathways
4m ago
Radio
More
Play
More

Footer branding


Footer main navigation

  • About Us
  • Contact Us
  • Privacy Policy
  • Sign in

HMP Global Products

  • HMP Global Learning Network
  • Consultant360
  • VRTX

Copyright branding

© 2023 HMP Global. Aggrego is a trademark of HMP Global. All Rights Reserved.

<!-- BEGIN ADVERTSERVE CODE -->
<div id="mobile_block_ad_1"><script type="text/javascript">
var _avp = _avp || [];
_avp.push({ tagid: 'mobile_block_ad_1', alias: '/', type: 'banner', zid: 1669, pid: 0, onscroll: 0, inview: true, secure: true });
</script></div>
<!-- END ADVERTSERVE CODE -->

Home

Site branding - mobile

Upper navigation

  • Today
    Today
  • Following
    Following
  • Specialties
    Specialties

Main navigation

  • News
    news
  • TV
    TV
  • Radio
    Radio
  • Conference Hub
    Conf hub
  • Originals
    Originals

Partners links

  • Advances
    Advances

User imageSign in

Register

Additional navigation- 1

  • Acute Basal Cell Carcinoma
  • Acute Lymphoblastic Leukemia
  • Acute Myeloid Leukemia
  • Breast Cancer
  • Early Breast Cancer
  • CAR-T Cell Therapy
  • Chronic Lymphocytic Leukemia
  • Colorectal Cancer
  • Cutaneous Squamous-Cell Carcinoma
  • Diffuse Large B-Cell Lymphoma
  • FDA Approvals
  • Febrile Neutropenia
  • Follicular Lymphoma
  • Gastrointestinal Cancer
  • Genitourinary Cancer
  • Gynecologic Cancer
  • Head and Neck Cancer
  • Healthcare Policy
  • Hematologic Malignancies
  • Immuno Oncology
  • Liver Cancer
  • Lung Cancer
  • Lymphoma
  • Multiple Myeloma
  • Myelofibrosis
  • Non-Small Cell Lung Cancer
  • Oncology Nursing
  • Pediatric Oncology
  • Radiation Oncology
  • Renal Cell Carcinoma
  • Sarcoma
  • Supportive Care
  • Surgical Oncology
  • Urethral Carcinoma